Siemens Healthineers AG
Siemens Healthineers AG Fundamental Analysis
Siemens Healthineers AG (SMMNY) shows moderate financial fundamentals with a PE ratio of 21.98, profit margin of 9.65%, and ROE of 11.13%. The company generates $44.2B in annual revenue with moderate year-over-year growth of 4.53%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 41.1/100 based on profitability, valuation, growth, and balance sheet metrics. The D grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze SMMNY's fundamental strength across five key dimensions:
Efficiency Score
WeakSMMNY struggles to generate sufficient returns from assets.
Valuation Score
ExcellentSMMNY trades at attractive valuation levels.
Growth Score
WeakSMMNY faces weak or negative growth trends.
Financial Health Score
ExcellentSMMNY maintains a strong and stable balance sheet.
Profitability Score
WeakSMMNY struggles to sustain strong margins.
Key Financial Metrics
Is SMMNY Expensive or Cheap?
P/E Ratio
SMMNY trades at 21.98 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, SMMNY's PEG of -24.67 indicates potential undervaluation.
Price to Book
The market values Siemens Healthineers AG at 2.52 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 17.78 times EBITDA. This signals the market has high growth expectations.
How Well Does SMMNY Make Money?
Net Profit Margin
For every $100 in sales, Siemens Healthineers AG keeps $9.65 as profit after all expenses.
Operating Margin
Core operations generate 14.72 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $11.13 in profit for every $100 of shareholder equity.
ROA
Siemens Healthineers AG generates $4.78 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Siemens Healthineers AG produces operating cash flow of $5.31B, showing steady but balanced cash generation.
Free Cash Flow
Siemens Healthineers AG produces free cash flow of $3.67B, offering steady but limited capital for shareholder returns and expansion.
FCF Per Share
Each share generates $0.81 in free cash annually.
FCF Yield
SMMNY converts 1.94% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
21.98
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-24.67
vs 25 benchmark
P/B Ratio
Price to book value ratio
2.52
vs 25 benchmark
P/S Ratio
Price to sales ratio
4.28
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.82
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.04
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.11
vs 25 benchmark
ROA
Return on assets percentage
0.05
vs 25 benchmark
ROCE
Return on capital employed
0.11
vs 25 benchmark
How SMMNY Stacks Against Its Sector Peers
| Metric | SMMNY Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 21.98 | 29.45 | Better (Cheaper) |
| ROE | 11.13% | 779.00% | Weak |
| Net Margin | 9.65% | -24930.00% (disorted) | Weak |
| Debt/Equity | 0.82 | 0.26 | Weak (High Leverage) |
| Current Ratio | 1.04 | 4.65 | Neutral |
| ROA | 4.78% | -19333.00% (disorted) | Weak |
SMMNY outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Siemens Healthineers AG's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
44.62%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
35.94%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
52.81%
Industry Style: Defensive, Growth, Innovation
High Growth